Table 4.

Details of post-ESD bleeding and delayed bleeding

	SLE group (n = 69)	Non-SLE group (n = 73)	p values
Post-ESD bleeding	15/69 (21.7%)	16/73 (21.9%)	0.98
Single antiplatelet	3/32 (9.4%)	4/37 (10.8%)	0.84
Single anticoagulant	1/16 (6.3%)	3/20 (15.0%)	0.41
Multiple therapy	11/21 (52.4%)	9/16 (56.2%)	0.82
Early bleeding	1/69 (1.4%)	2/73 (2.7%)	0.59
Delayed bleeding	14/69 (20.3%)	14/73 (19.2%)	0.87
Single antiplatelet	3/32 (9.4%)	3/37 (8.1%)	0.85
Single anticoagulant	1/16 (6.3%)	3/20 (15.0%)	0.41
Multiple therapy	10/21 (47.6%)	8/16 (50.0%)	0.89